Literature DB >> 18382223

Drug use and health among prison inmates.

Manop Kanato1.   

Abstract

PURPOSE OF REVIEW: Health problems related to substance use are investigated and monitored throughout the world by both international organizations and governments. It is well recognized that prison inmates are a vulnerable group of the population. Research on this group is minimal compared with the general population. The problem of drug use and health consequences among this subpopulation is significant and needs to be explored. RECENT
FINDINGS: A higher prevalence of drug use is found among prison inmates than among the general population. The health status of prison inmates seems to be lower because of both the inmates' behavior and the prison environment. Various communicable diseases are commonly found such as hepatitis C virus, HIV, and syphilis.
SUMMARY: The health of prison inmates tended to be worse than in the general population, particularly for those who use drugs. Based on the principle of human rights and equity of access, healthcare services provided to prison inmates should be equivalent to those provided to the general population.

Entities:  

Mesh:

Year:  2008        PMID: 18382223     DOI: 10.1097/YCO.0b013e3282fc985c

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  16 in total

1.  Prior incarceration and barriers to receipt of services among entrants to alternative to incarceration programs: a gender-based disparity.

Authors:  Elwin Wu; Nabila El-Bassel; Louisa Gilbert; Leona Hess; Hae-Nim Lee; Tawandra L Rowell
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Gender Differences Among Prisoners With Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine Treatment.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Monique E Wilson; Robert P Schwartz; Kevin E O'Grady
Journal:  J Offender Rehabil       Date:  2013-01-01

3.  Effectiveness of Drug Camps in Treatment of Substance Abuse in Thailand.

Authors:  Manop Kanato; Poonrut Leyatikul
Journal:  J Community Health       Date:  2017-12

4.  Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Kevin E O'Grady
Journal:  J Offender Rehabil       Date:  2013-10

5.  Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.

Authors:  Michael S Gordon; Frank J Vocci; Terrence T Fitzgerald; Kevin E O'Grady; Charles P O'Brien
Journal:  Contemp Clin Trials       Date:  2016-12-20       Impact factor: 2.226

6.  A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady; Terrence T Fitzgerald; Frank J Vocci
Journal:  Drug Alcohol Depend       Date:  2017-01-11       Impact factor: 4.492

7.  Medication-assisted treatment research with criminal justice populations: challenges of implementation.

Authors:  Michael S Gordon; Timothy W Kinlock; Patrice M Miller
Journal:  Behav Sci Law       Date:  2011 Nov-Dec

8.  A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Terrence T Fitzgerald; Kevin E O'Grady; Frank J Vocci
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

9.  Predictors of drug use in prison among incarcerated Black men.

Authors:  Tawandra L Rowell; Elwin Wu; Carl L Hart; Rahwa Haile; Nabila El-Bassel
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-02       Impact factor: 3.829

10.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.